Cancer stem-like cells in Epstein-Barr virus-associated nasopharyngeal carcinoma
Publication in refereed journal

Times Cited
Altmetrics Information

Other information
AbstractAlthough the Epstein-Barr virus (EBV) has spread to all populations in the world, EBV-associated nasopharyngeal carcinoma (NPC) is prevalent only in South China and Southeast Asia. The role of EBV in the malignant transformation of nasopharyngeal epithelium is the main focus of current researches. Radiotherapy and chemoradiotherapy have been successful in treating early stage NPC, but the recurrence rates remain high. Unfortunately, local relapse and metastasis are commonly unresponsive to conventional treatments. These recurrent and metastatic lesions are believed to arise from residual or surviving cells that have the properties of cancer stem cells. These cancer stem-like cells (CSCs) have the ability to selfrenew, differentiate, and sustain propagation. They are also chemo-resistant and can form spheres in anchorage-independent environments. This review summarizes recent researches on the CSCs in EBVassociated NPC, including the findings regarding cell surface markers, stem cell-related transcription factors, and various signaling pathways. In particular, the review focuses on the roles of EBV latent genes [latent membrane protein 1 (LMP1) and latent membrane protein 2A (LMP2A)], cellular microRNAs, and adenosine triphosphate (ATP)-binding cassette chemodrug transporters in contributing to the properties of CSCs, including the epithelial-mesenchymal transition, stem-like transition, and chemo-resistance. Novel therapeutics that enhance the efficacy of radiotherapy and chemoradiotherapy and inhibitors that suppress the properties of CSCs are also discussed.
All Author(s) ListLun S.W.-M., Cheung S.-T., Lo K.-W.
Journal nameChinese Journal of Cancer
Volume Number33
Issue Number11
PublisherLandes Bioscience
Place of PublicationUnited States
Pages529 - 538
LanguagesEnglish-United Kingdom
KeywordsCancer stem-like cells, Epstein-Barr virus, Microrna, Nasopharyngeal carcinoma, Signalling pathway

Last updated on 2020-27-09 at 00:19